HCW Biologics Inc. Common Stock (HCWB) Stock Price

HCWBStock

$1.24−94.86%52W

Market Cap$2.77M

P/E—

PEG Ratio—

Div yield—

Beta2.30

HCWB Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-50.29%

Price vs S&P 500 (4W)-33.75%

VGM Score55.19

Book Value / Share (Quarterly)$4.59

P/TBV (Annual)1.11x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-79.94%

Cash Flow / Share (Quarterly)$-7.50

Price vs S&P 500 (YTD)-90.66%

Gross Margin (TTM)96.09%

Net Profit Margin (TTM)-15.32%

EPS (TTM)$-10.91

10-Day Avg Trading Volume0.26M

EPS Excl Extra (TTM)$-10.91

Revenue Growth (5Y)-57.90%

EPS (Annual)$-22.77

ROI (Annual)-83.14%

Gross Margin (Annual)19.99%

Net Profit Margin (5Y Avg)-3418.02%

Cash / Share (Quarterly)$0.46

Revenue Growth QoQ (YoY)1969.77%

ROA (Last FY)-32.46%

Revenue Growth TTM (YoY)710.08%

EBITD / Share (TTM)$-1.91

ROE (5Y Avg)-115.76%

Operating Margin (TTM)23.15%

Cash Flow / Share (Annual)$-24.50

P/B Ratio0.37x

P/B Ratio (Quarterly)1.07x

Net Income / Employee (Annual)$-318,400

EV / Revenue (TTM)1.28x

Net Interest Coverage (TTM)-4.76x

ROA (TTM)-21.45%

EPS Incl Extra (Annual)$-22.77

Current Ratio (Annual)0.11x

Quick Ratio (Quarterly)0.05x

3-Month Avg Trading Volume0.33M

52-Week Price Return-94.86%

Revenue / Employee (TTM)$268,200

Tangible BV / Share (Quarterly)$0.66

P/S Ratio (Annual)51.13x

Asset Turnover (Annual)0.00x

52-Week High$26.13

Operating Margin (5Y Avg)-3324.26%

EPS Excl Extra (Annual)$-22.77

CapEx CAGR (5Y)-29.10%

26-Week Price Return-40.38%

Quick Ratio (Annual)0.10x

13-Week Price Return-69.00%

Total Debt / Equity (Annual)2.46x

Current Ratio (Quarterly)0.06x

Enterprise Value$8.59M

Revenue / Share Growth (5Y)6.17%

Asset Turnover (TTM)0.26x

Revenue / Employee (Annual)$2,200

Pretax Margin (Annual)-14677.69%

Cash / Share (Annual)$3.57

3-Month Return Std Dev121.11%

Net Income / Employee (TTM)$-223,300

EBITDA Interim CAGR (5Y)0.07%

ROE (Last FY)-287.90%

Net Interest Coverage (Annual)-0.85x

EPS Basic Excl Extra (Annual)$-22.77

Receivables Turnover (TTM)334.78x

Total Debt / Equity (Quarterly)0.88x

EPS Incl Extra (TTM)$-10.91

Receivables Turnover (Annual)0.18x

ROI (TTM)-8.59%

P/S Ratio (TTM)0.41x

Pretax Margin (5Y Avg)-3418.02%

Revenue / Share (Annual)$0.16

Tangible BV / Share (Annual)$1.04

Price vs S&P 500 (52W)-110.39%

Year-to-Date Return-78.73%

5-Day Price Return-16.22%

EPS Normalized (Annual)$-22.77

ROA (5Y Avg)-55.06%

Net Profit Margin (Annual)-14677.69%

Month-to-Date Return-27.49%

Cash Flow / Share (TTM)$-0.52

EBITD / Share (Annual)$-21.35

Operating Margin (Annual)-14201.49%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-61.80%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-10.91

P/TBV (Quarterly)1.75x

P/B Ratio (Annual)0.95x

Pretax Margin (TTM)-10.40%

Book Value / Share (Annual)$5.06

Price vs S&P 500 (13W)-71.69%

Beta2.30x

Revenue / Share (TTM)$5.05

ROE (TTM)-19.32%

52-Week Low$1.14

vGradeA

gGradeB

mGradeF

vgmGradeC

HCWB Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 14, 2026	-$1.98	-$11.58	-484.85%(-$9.60)
Q1 2026	May 14, 2026	-$2.64	$2.22	+184.09%(+$4.86)
Q4 2025	Mar 31, 2026	-$5.04	-$6.12	-21.43%(-$1.08)
Q3 2025	Nov 14, 2025	$9.48	-$12.12	-227.85%(-$21.60)
Q2 2025	Aug 18, 2025	$10.80	-$40.74	-477.22%(-$51.54)

HCWB Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.14

Industry Peers — Pharmaceuticals(574)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth TTM (YoY)	Gross Margin (TTM)	EPS Growth (5Y)	Price
HCWBHCW Biologics Inc. Common Stock	A	B	F	0.4x	710.1%	96.1%	—	$1.24
LLYEli Lilly & Co.	D	B	A	14.9x	49.6%	83.4%	27.6%	$1257.03
JNJJohnson & Johnson	D	C	B	6.2x	7.8%	67.7%	14.9%	$255.56
ABBVABBVIE INC.	D	C	A	7.8x	10.4%	72.8%	-2.9%	$285.42
MRKMerck & Co., Inc.	D	C	A	5.4x	4.6%	77.3%	21.2%	$145.95
NVSNovartis AG	C	C	B	4.9x	3.3%	75.0%	15.3%	$150.62
AZNAstraZeneca PLC	C	B	B	4.3x	8.6%	81.3%	21.9%	$165.41
ABTAbbott Laboratories	C	C	B	3.9x	8.1%	56.8%	8.2%	$104.89
NVONovo-Nordisk A/S	B	C	C	3.5x	5.6%	80.7%	20.7%	$38.83
PFEPfizer Inc.	C	D	A	2.6x	-0.2%	74.7%	-3.5%	$29.58
VRTXVertex Pharmaceuticals Inc	D	C	B	10.1x	10.2%	86.0%	8.3%	$499.74
BMYBristol-Myers Squibb Co.	B	B	B	2.5x	3.1%	71.7%	—	$59.75
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	C	C	B	2.3x	5.0%	73.6%	-0.5%	$49.51
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	D	B	1.8x	13.4%	72.8%	-8.2%	$40.61
REGNRegeneron Pharmaceuticals Inc	C	C	A	5.2x	9.3%	86.0%	6.3%	$790.74
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	A	2.1x	3.1%	65.5%	-12.6%	$19.67
TEVATeva Pharmaceutical Industries Limited	D	C	A	2.8x	4.1%	52.9%	—	$41.50
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	B	6.3x	31.1%	88.5%	—	$369.06
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	A	13.8x	10.0%	—	-12.1%	$60.96
ZTSZOETIS INC.	C	C	B	3.5x	1.4%	71.6%	12.0%	$79.38
ALNYAlnylam Pharmaceuticals, Inc.	D	A	C	6.5x	95.1%	79.7%	—	$231.83
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	3215.5x	-67.6%	81.2%	—	$33.53
UTHRUnited Therapeutics Corp	C	C	B	7.2x	2.5%	86.1%	19.3%	$533.12
GMABGenmab A/S ADS	D	C	A	5.5x	22.3%	93.0%	6.8%	$37.00
VTRSViatris Inc. Common Stock	B	C	A	1.5x	4.4%	40.3%	—	$18.66
INSMInsmed, Inc.	F	A	C	18.5x	185.8%	83.5%	—	$96.27
ASNDAscendis Pharma A/S Ordinary Share	D	A	B	11.9x	113.3%	91.3%	—	$225.25
JAZZJazz Pharmaceuticals, Inc.	B	C	B	3.0x	12.6%	88.4%	-1.4%	$210.23
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	18.2x	202.4%	94.4%	—	$66.39
CORTCorcept Therapeutics Inc.	F	C	A	14.3x	16.0%	98.3%	-0.5%	$110.16
ELANElanco Animal Health Incorporated Common Stock	D	B	B	2.3x	11.9%	55.4%	29.9%	$23.55
SMMTSummit Therapeutics Inc. Common Stock	F	—	C	12187.5x	—	—	—	$14.63
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	C	B	3.1x	-0.9%	61.4%	16.5%	$13.07
BMRNBioMarin Pharmaceuticals Inc	C	C	B	3.1x	11.2%	79.6%	-17.0%	$54.68
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	8.1x	149.0%	91.5%	—	$449.74
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	213.8x	2928.4%	—	—	$84.95
CYTKCytokinetics Inc.	F	D	B	127.3x	-21.1%	—	—	$61.95
PTGXProtagonist Therapeutics, Inc	F	B	B	29.5x	34.8%	—	—	$128.75
TGTXTG Therapeutics, Inc.	D	B	B	10.3x	76.1%	82.4%	—	$53.97
AXSMAxsome Therapeutics, Inc	D	B	C	10.6x	56.9%	93.2%	—	$157.14
ARWRArrowhead Research Corporation	D	A	C	11.8x	16.9%	—	—	$55.90
ABVXAbivax SA American Depositary Shares	—	—	C	—	—	—	—	$88.13
SYRESpyre Therapeutics, Inc. Common Stock	—	—	B	5995.2x	—	—	—	$79.90
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	8.2x	-7.5%	98.2%	—	$42.94
ALKSAlkermes Inc. plc	D	C	B	4.1x	10.8%	84.6%	—	$41.22
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	789.2x	—	—	—	$241.76
AMRXAmneal Pharmaceuticals, Inc. Class A Common Stock	D	C	A	2.0x	9.3%	39.3%	-18.4%	$19.18
KNSAKiniksa Pharmaceuticals International, plc Class A Ordinary Shares	D	B	A	7.3x	58.9%	89.8%	—	$78.59
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	24.7x	53.5%	70.9%	—	$86.17
LGNDLigand Pharmaceuticals Inc.	D	B	B	20.3x	54.9%	95.4%	—	$295.54
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	—	—	—	—	$142.78

About HCW Biologics Inc. Common Stock

HCW Biologics is a clinical-stage biopharmaceutical company developing immunotherapies to treat age-related diseases by targeting chronic inflammation. The company uses its proprietary TOBI discovery platform to generate two lead candidates: HCW9218, which neutralizes growth factors and stimulates immune cells, and HCW9302, which activates regulatory T cells to reduce inflammation. This approach targets the inflammation-aging link to potentially extend healthspan across multiple indications.

HCWB Insider Transactions

BuyJul 29, 2026
WONG HING C
Chief Executive Officer
Shares: 23,210Value: $59,998
BuyJul 29, 2026
FLOWERS LEE
Officer
Shares: 7,736Value: $19,998
BuyJul 29, 2026
GARRETT SCOTT T
Director
Shares: 7,736Value: $19,998

Open-market buys and sells filed with the SEC over the last 90 days. Grants, gifts and option exercises are excluded.

All insider transactions for July 2026

Companies in Related Industries

PMCBPharmaCyte Biotech, Inc. Common StockBiological Products
SNESSenesTech, Inc. Common StockAgricultural Chemicals
AKANAkanda Corp. Common SharesPharmaceutical Preparations
CLDICalidi Biotherapeutics, Inc.Biological Products
VIVSVivoSim Labs, Inc. Common StockBiological Products
IMCCIM Cannabis Corp. Common SharesPharmaceutical Preparations
CNEYCN Energy Group Inc. Class A Ordinary SharesIndustrial Chemicals
BCABBioAtla, Inc. Common StockBiological Products

Same SIC sector, outside this company's own industry.

Analyst Sentiment

4.1

Buy

Consensus rating

52-Week Range

Low$1.14

High$26.13